Navigation Links
National Law Firm Baron and Budd Helping Women with Alleged Injuries from Lipitor Use Understand the Lipitor Lawsuit
Date:8/31/2013

ST. LOUIS (PRWEB) August 31, 2013

The national law firm Baron and Budd has begun outreach to help women allegedly injured by statin drugs, such as Lipitor, understand their legal options. Prescribed to lower cholesterol, Lipitor has recently come into question because of the drug's alleged risk of developing type 2 diabetes in female patients. (In re: Lipitor (Atorvastatin) Litigation, MDL No. 2459 (JPML)).

"Type 2 diabetes is a dangerous and life-long condition that increases the patient's risk for blindness, strokes, heart attacks and kidney disease,” said Russell Budd of Baron and Budd. “What's most concerning is that, according to court documents, some healthy women who begin taking Lipitor as part of a preventative measure to decrease their odds of developing heart disease are allegedly developing type 2 diabetes - a condition that puts patients at an increased risk for many serious issues."

In addition to the increased risk of blindness, stroke, heart attack and heart disease that comes with type 2 diabetes, patients who find themselves diagnosed with type 2 diabetes must also commit themselves to a strict diet and must routinely keep track of their blood sugar levels. (http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm293330.htm)

By educating women who allegedly developed diabetes as a result of Lipitor use, Baron and Budd hopes to assist those harmed get back on their feet.

At this time, the Lipitor lawyers at Baron and Budd are reviewing claims involving women with a Body Mass Index (BMI) of 35 or under who developed diabetes while taking Lipitor. Anyone who is concerned may contact Baron and Budd for a free and confidential evaluation of their potential case. Please call the Lipitor lawsuit lawyers at 1.866.844.4556 or email them at info(at)baronbudd(dot)com. Learn more at the firm’s website at http://baronandbudd.com/areas-of-practice/pharmaceuticals/lipitor-lawsuit.

The national plaintiffs' law firm of Baron and Budd is a leading national firm and has a dedicated team focused on dangerous drugs and medical devices. Baron and Budd was recently a finalist for the Public Justice 2013 Trial Lawyer of the Year Award. Lawyers at Baron and Budd have been nominated as finalists for the Trial Lawyer of the Year Award four times within the last six years.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11070969.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. NewsWatch Featured “TapForMessage”, an NFC Enabled Video Greeting, on National Television
2. Malibu Senior Center Invites Resource Speakers for the National Falls Prevention Awareness Day
3. Mercy College Awarded Grant from the National Science Foundation to Expand STEM Programs
4. Luciana Lagana and Gregory Graham’s Feature Screenplay “Old River Road” Wins ‘Best Dramatic Screenplay’ at the 2013 AOF International Film Festival
5. Pretty Mommies Announces a National Sales Campaign with UBS Aesthetics
6. Aeromedevac International Air Ambulance and Medical Flight Company Soars with Service Around the World
7. Miracle-Ear Launches Revamped National Website
8. Report Released By the National Academy of Social Insurance This Month Shows Georgia To Be One of 22 States Whose Workers’ Compensation Benefits Payments Dropped in 2011
9. 2nd Annual Brains Matter Conference Brings Together National Brain Tumor Experts to the Pacific Northwest
10. Humpty Dumpty Day School is The First Educational First Steps Assisted Center to Reach National Accreditation in Tarrant County
11. Voyance Announces 2012/2013 National APEX Quality Award Winners for Healthcare Excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... International Protein, ... nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in Hilton ... and nutritional scientist who was determined to create a line of products that would ...
(Date:1/20/2017)... ... , ... “Mary Magdalene: Grace is Greater than Sin”: a unique and ... Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the creation of published ... with countless women who had little knowledge of the female characters portrayed in the ...
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... 20, 2017 , ... “The Land of More and More”: a brilliant ... hunger, and shares the simple and achievable answer. “The Land of More and More” ... Fairview Missionary Church in Angola, Indiana where he works with the children’s ministry department. ...
(Date:1/19/2017)... ... 19, 2017 , ... Next week after January 20th, the fear for many ... that circumvent health needs of over 30 million. Many interviews with Dr. Carol Francis ... government public servants were suppose to prioritize. Interviews provided below. , Among ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , Jan. 19, 2017 This ... the current and future scenario of the global market. ... rising opioid consumption. Severe chronic constipation is a major ... to traditional laxatives. Hence, novel targeted therapy has been ... OIC sufferers, launch of targeted medicines, and growing awareness ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... January 19, 2017 According to a study ... is set to witness a CAGR of 6.5% during the forecast ... will continue to be the leading market for cryotherapy globally ... ... emphasizing on ensuring affordable and adequate supply of gas in order ...
Breaking Medicine Technology: